Lihong Shi

7PUBLICATIONS

37CO-AUTHORS

Tumour immunologyHaematological tumoursRegenerative medicine (incl. stem cells)Biologically active moleculesGlycoconjugates

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Sep 01, 2026

Discovery of BMS-986449: A Potent, Selective Degrader of the Transcription Factors IKZF2 (Helios) and IKZF4 (Eos) to Target Regulatory T Cells in Solid Tumors.

|Feb 11, 2026

Discovery of BMS-986458, a Potent and Selective B-Cell Lymphoma 6 Protein Ligand-Directed Degrader, for the Treatment of B-Cell Non-Hodgkin Lymphoma.

Deborah S Mortensen, Hunter P Shunatona, Natalie Holmberg-Douglas

|Nov 24, 2025

Discovery and Characterization of Novel BLIMP-1 Heterobifunctional Ligand-Directed Degraders.

Bryan J Simmons, Lynda Groocock, Jesus Moreno

|Oct 07, 2025

Discovery of Potent and Selective BCL6 Ligand-Directed Degrader (LDD), BCL6-760.

Hunter P Shunatona, Natalie Holmberg Douglas, Jayce Rhodes

|Sep 25, 2025

Application of Weighted Interaction-Fingerprints for Rationalizing Neosubstrate Potency and Selectivity of Cereblon-Based Molecular Glues.

Guilian Luchini, Shuang Liu, Hannah L Powers

|Sep 18, 2024

Asymmetric Dirhodium-Catalyzed Modification of Immunomodulatory Imide Drugs and Their Biological Assessment.

William F Tracy, Geraint H M Davies, Lei Jia

Pageof 2

Frequent Collaborators

Gody Khambatta

Jinyi Zhu

Deborah S Mortensen

Hunter P Shunatona

Lynda Groocock

Natalie Holmberg-Douglas

Zhenghang Sun

Jennifer R Riggs

Jesus Moreno

Andrew P Degnan

Frequent Collaborators

Gody Khambatta

Jinyi Zhu

Deborah S Mortensen

Hunter P Shunatona